多发性硬化相关三叉神经痛的经皮甘油毁损术长期回顾性队列研究
该单中心回顾性队列研究分析了1983至2018年间219例接受401次经皮甘油毁损术的患者,其中多发性硬化相关三叉神经痛(MS-TN)182次、特发性三叉神经痛(ITN)219次。结果显示两组初始无痛缓解率相似(89.6%对89.6%),初始术后复发时间无显著差异,但重复术后MS-TN复发时间显著长于ITN(2.3±0.5年对1.2±0.2年,P<0.05)。围手术期感觉减退可高度预测无痛生存。
要点
- MS-TN患者经皮甘油毁损术后初始无痛缓解率与ITN相当(89.6%对89.6%,P=0.726)。
- 重复甘油毁损术后MS-TN疼痛复发时间显著长于ITN(2.3±0.5年对1.2±0.2年,P<0.05)。
- 围手术期感觉减退可高度预测无痛生存(P<0.01)。
核心结论
- MS-TN患者接受甘油毁损术可获得有意义的疼痛缓解,疗效与ITN患者相当。
- 首次与重复甘油毁损术疗效相当。
研究设计与样本
- 单中心回顾性病历审查,纳入1983至2018年间219例接受401次甘油毁损术的患者。
- MS-TN组182次手术,ITN组219次手术。
主要发现
- 初始无痛缓解率组间相似(P=0.726):MS-TN首次89.6%、MS-TN重复91.9%、ITN首次89.6%、ITN重复87.0%。
- 首次甘油毁损术后中位复发时间MS-TN为2.7±1.3年,ITN为2.1±0.6年,组间无显著差异(P=0.87)。
- 重复甘油毁损术后复发时间MS-TN为2.3±0.5年,ITN为1.2±0.2年,差异有统计学意义(P<0.05)。
- 围手术期感觉减退可高度预测无痛生存(P<0.01)。
临床怎么用
- 甘油毁损术可用于药物难治性MS-TN的疼痛缓解,首次和重复手术均可考虑。
- 围手术期出现感觉减退可能提示较好的无痛生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The prevalence of trigeminal neuralgia (TN) in patients with multiple sclerosis (MS-TN) is higher than in the general population (idiopathic TN [ITN]). Glycerol rhizotomy (GR) is a percutaneous lesioning surgery commonly performed for the treatment of medically refractory TN. While treatment for acute pain relief is excellent, long-term pain relief is poorer. The object of this study was to assess the efficacy of percutaneous retrogasserian GR for the treatment of MS-TN versus ITN. METHODS: A retrospective chart review was performed, identifying 219 patients who had undergone 401 GR procedures from 1983 to 2018 at a single academic institution. All patients were diagnosed with medically refractory MS-TN (182 procedures) or ITN (219 procedures). The primary outcome measures of interest were immediate pain relief and time to pain recurrence following initial and repeat GR procedures. Secondary outcomes included medication usage and presence of periprocedural hypesthesia. RESULTS: The initial pain-free response rate was similar between groups (p = 0.726): MS-TN initial GR 89.6%; MS-TN repeat GR 91.9%; ITN initial GR 89.6%; ITN repeat GR 87.0%. The median time to recurrence after initial GR was similar between MS-TN (2.7 ± 1.3 years) and ITN (2.1 ± 0.6 years) patients (p = 0.87). However, there was a statistically significant difference in the time to recurrence after repeat GR between MS-TN (2.3 ± 0.5 years) and ITN patients (1.2 ± 0.2 years; p < 0.05). The presence of periprocedural hypesthesia was highly predictive of pain-free survival (p < 0.01). CONCLUSIONS: Patients with MS-TN achieve meaningful pain relief following GR, with an efficacy comparable to that following GR in patients with ITN. Initial and subsequent GR procedures are equally efficacious.
引用
- Staudt MD, Joswig H, Pickett GE, et al. Percutaneous glycerol rhizotomy for trigeminal neuralgia in patients with multiple sclerosis: a long-term retrospective cohort study. J Neurosurg. 2019. PMID: 30978686. doi:10.3171/2019.1.JNS183093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。